PETQ
Price
$17.04
Change
+$0.20 (+1.19%)
Updated
May 3, 6:59 PM EST
5 days until earnings call
VTRS
Price
$11.79
Change
+$0.19 (+1.64%)
Updated
May 3, 6:59 PM EST
5 days until earnings call
Ad is loading...

Analysis and predictions PETQ vs VTRS

Header iconPETQ vs VTRS Comparison
Open Charts PETQ vs VTRSBanner chart's image
PetIQ
Price$17.04
Change+$0.20 (+1.19%)
Volume$96.94K
CapitalizationN/A
Viatris
Price$11.79
Change+$0.19 (+1.64%)
Volume$3M
CapitalizationN/A
View a ticker or compare two or three
PETQ vs VTRS Comparison Chart

Loading...

PETQDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VTRSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PETQ vs. VTRS commentary
May 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PETQ is a StrongBuy and VTRS is a Buy.

COMPARISON
Comparison
May 04, 2024
Stock price -- (PETQ: $16.84 vs. VTRS: $11.60)
Brand notoriety: PETQ and VTRS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PETQ: 77% vs. VTRS: 92%
Market capitalization -- PETQ: $539.9M vs. VTRS: $14.18B
PETQ [@Pharmaceuticals: Other] is valued at $539.9M. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PETQ’s FA Score shows that 1 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • PETQ’s FA Score: 1 green, 4 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than PETQ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PETQ’s TA Score shows that 6 TA indicator(s) are bullish while VTRS’s TA Score has 5 bullish TA indicator(s).

  • PETQ’s TA Score: 6 bullish, 4 bearish.
  • VTRS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both PETQ and VTRS are a good buy in the short-term.

Price Growth

PETQ (@Pharmaceuticals: Other) experienced а +3.19% price change this week, while VTRS (@Pharmaceuticals: Other) price change was +1.13% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.19%. For the same industry, the average monthly price growth was -4.43%, and the average quarterly price growth was +19088.38%.

Reported Earning Dates

PETQ is expected to report earnings on Aug 06, 2024.

VTRS is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+3.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for PETQ with price predictions.
OPEN
A.I.dvisor published
a Summary for VTRS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than PETQ($540M). PETQ has higher P/E ratio than VTRS: PETQ (264.14) vs VTRS (238.80). VTRS YTD gains are higher at: 8.163 vs. PETQ (-14.734). VTRS has higher annual earnings (EBITDA): 3.52B vs. PETQ (81.4M). VTRS has more cash in the bank: 1.18B vs. PETQ (116M). PETQ has less debt than VTRS: PETQ (468M) vs VTRS (18.4B). VTRS has higher revenues than PETQ: VTRS (15.4B) vs PETQ (1.1B).
PETQVTRSPETQ / VTRS
Capitalization540M14.2B4%
EBITDA81.4M3.52B2%
Gain YTD-14.7348.163-181%
P/E Ratio264.14238.80111%
Revenue1.1B15.4B7%
Total Cash116M1.18B10%
Total Debt468M18.4B3%
FUNDAMENTALS RATINGS
PETQ vs VTRS: Fundamental Ratings
PETQ
VTRS
OUTLOOK RATING
1..100
48
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
16
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8989
PRICE GROWTH RATING
1..100
5850
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (16) in the null industry is significantly better than the same rating for PETQ (95) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew significantly faster than PETQ’s over the last 12 months.

VTRS's Profit vs Risk Rating (100) in the null industry is in the same range as PETQ (100) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to PETQ’s over the last 12 months.

VTRS's SMR Rating (89) in the null industry is in the same range as PETQ (89) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to PETQ’s over the last 12 months.

VTRS's Price Growth Rating (50) in the null industry is in the same range as PETQ (58) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to PETQ’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is in the same range as PETQ (3) in the Pharmaceuticals Major industry. This means that VTRS’s stock grew similarly to PETQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PETQVTRS
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
58%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 17 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
61%
View a ticker or compare two or three
Ad is loading...
PETQDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VTRSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEA126.602.23
+1.79%
Lear Corp
LGMK0.810.01
+1.72%
LogicMark
CAC32.130.35
+1.10%
Camden National Corp
RVPH3.18-0.08
-2.45%
Reviva Pharmaceuticals Holdings
TSLX20.89-0.89
-4.09%
Sixth Street Specialty Lending

PETQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, PETQ has been loosely correlated with SNDL. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PETQ jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PETQ
1D Price
Change %
PETQ100%
-0.18%
SNDL - PETQ
36%
Loosely correlated
+2.25%
AMPH - PETQ
31%
Poorly correlated
+1.38%
ZTS - PETQ
30%
Poorly correlated
+5.51%
VTRS - PETQ
29%
Poorly correlated
-0.26%
DVAX - PETQ
29%
Poorly correlated
+0.34%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with PRGO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-0.26%
PRGO - VTRS
41%
Loosely correlated
+0.49%
TEVA - VTRS
38%
Loosely correlated
+0.72%
ELAN - VTRS
37%
Loosely correlated
+2.43%
ALKS - VTRS
35%
Loosely correlated
-0.62%
SNDL - VTRS
30%
Poorly correlated
+2.25%
More